Statistical programming is a well-known clinical trial and data analytics language for many pharmaceutical industries, including healthcare, clinical research, and biotech organizations. It plays an important role in clinical trials, including data processing, modeling, data warehousing, statistical analysis, application development, data analytics and management, and reporting.
This blog delves into the elucidation of how statistical programming drives safety, efficiency, and innovation in clinical research, bringing life to drug-saving medications for healthcare.
What is clinical statistical programming?
statistical programming services are used for clinical trials and data analytics in pharmaceuticals, healthcare, clinical research, and biotech organizations. Thus, these clinical trials are making impactful changes in patients’ lives.
Prevalence of statistical programming and other programming languages in clinical research.
Data, from patient records to clinical trials, has become an imperative part of the healthcare industry. Healthcare organizations rely on data to make informed decisions and improve patient care. Some data languages used in the healthcare and pharmaceutical industries are statistical programming, R, Python, SQL, Java, etc.
Programming languages like “R” are normally used in data analysis and can easily convert complex data into visual formats, which is needed in healthcare.
Thus, many programming languages are emerging from the succession of clinical research. Statistical programming has become one of the most important tools in which many companies trust to invest. It has become the industry standard for data analytics on large datasets. Statistical programming is a flexible platform for manipulating, analyzing, processing, and reporting.
The impact of Statistical programming on drug development
The role of effective data handling in pharmaceutical research is integrated. Drug development automatically provides data transformation and analysis integrity by applying statistical programming services.
- An accurate and thorough history of each programming run is automatically captured and preserved for the data-related activities conducted strictly within the statistical programming and drug development environments.
- Through statistical programming, information within drug development services is organized in a familiar file hierarchy mechanism, allowing authorized users access to the parts of research content relevant to their work.
- Clinical trials have traditionally relied on paper-based processes to collect the information and manage the data. The emergence of electronic data capture (EDC) eliminates paper from the process, with the investigator site transcribing patient charts directly into the EDC system.
- Thus, the customers are beginning to adopt an information workflow where data flows directly from the EDC system to drug development for analysis and exploration through statistical programming. This methodology allows the biostatisticians and medical teams to have near-real-time access to the EDC data.
- Beyond these basic capabilities, statistical programming provides robust support for transforming data to the SDTM model using a centralized, streamlined, metadata-driven approach with clinical data integration.
Conclusion
SAS is globally recognized as the industry leader in analytics, the de facto standard for clinical data analysis, and an FDA standard for electronic submissions.
While the business benefits of modernizing clinical research include significant cost savings, efficiency improvements, accelerated time to regulatory approval, and faster time to market, we are also experiencing a widespread adoption of innovative approaches, such as decentralized clinical trials for developing new vaccines.
Global Pharma Tek offers extensive statistical programming services to assist pharmaceutical, biotechnology, and medical device companies effectively and efficiently.